Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2016 07:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results

Launch of Adzenys XR-ODT in Second Quarter of 2016 Company to Host Conference Call at 8:30am ET Today DALLAS/FORT WORTH, Texas, March 17, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc....
March 08, 2016 07:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Announces Date of Fourth Quarter and 2015 Fiscal Year Financial Results

DALLAS and FORT WORTH, Texas, March 08, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing and commercializing innovative extended-release...
February 16, 2016 16:47 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present at Upcoming Investor Conferences

DALLAS and FORT WORTH, Texas, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing and commercializing innovative...
January 27, 2016 19:46 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT™ (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older

DALLAS and FORT WORTH, Texas, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR)...
November 11, 2015 16:26 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics to Present at Stifel Healthcare Conference on November 18, 2015

DALLAS and FORT WORTH, Texas, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR)...
November 10, 2015 17:58 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Receives Complete Response Letter From the FDA for Cotempla XR-ODT

Company Announces Financial Results for the Third Quarter Ended September 30, 2015 Conference call scheduled for November 11, 2015 at 8:30am ET DALLAS and FORT WORTH, Texas, Nov. 10, 2015...
October 30, 2015 16:01 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Presents Data for Investigational ADHD Treatment Cotempla XR-ODT at AACAP's 62nd Annual Meeting

DALLAS/FORT WORTH, Texas, October 30, 2015 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with three late-stage proprietary, extended release (XR) product...
July 23, 2015 07:00 ET | Source: Neos Therapeutics, Inc.

Neos Therapeutics Announces Pricing of Initial Public Offering

DALLAS/FORT WORTH, Texas, July 23, 2015 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. ("Neos" or "the Company") today announced the pricing of its initial public offering of 4,800,000 shares of common...